Cytokinetics, Incorporated · NASDAQ:CYTK
Wierenga Wendell sold 4,032 Cytokinetics, Incorporated shares (Form 4)
Traded May 5, 2026 · Filed May 5, 2026
On May 5, 2026, Wierenga Wendell (Director) sold 4,032 Cytokinetics, Incorporated shares at US$75.00 for US$302K under a trading plan, leaving 32,637 shares. Filed May 5, 2026 (Form 4).
- Sold
- 4,032 shares
- Price
- US$75.00
- Value
- US$302K
- Holding after
- 32,637 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Option exercise | 4,032 | US$12.40 | 36,669 | Direct |
| May 5, 2026 | Common Stock | Sale | 4,032 | US$75.00 | 32,637 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Wierenga Wendell
- Cytokinetics, Incorporated shareholders
- Form 4 · Wierenga Wendell · Oct 20, 2026
- Form 4 · Wierenga Wendell · Jul 16, 2026
- Form 4 · Wierenga Wendell · May 27, 2026
- Form 4 · Wierenga Wendell · Apr 15, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026